Neurocrine Biosciences’ (NBIX) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a report published on Thursday, Benzinga reports. They currently have a $190.00 price target on the stock. Other analysts also recently issued reports about the stock. Oppenheimer lifted their price target on shares of Neurocrine Biosciences from $216.00 to […]
More Stories
Lebanon: WHO appeals for more support for civilians as crises intensify
The international community must come to the aid of Lebanon in the face of back-to-back crises and spillover from the...
News from the WHO: Governments progress on negotiations for a pandemic agreement to boost global preparedness for future emergencies https://ift.tt/Lp23hDT September 20, 2024 at 07:00AM
Published on September 20, 2024 at 07:00AM View on website
Middle East: Regional crisis risks engulfing Syria, UN envoy warns
The escalating regional tensions are drawing Syria deeper into conflict, the UN Special Envoy for the country warned on Tuesday,...
Steelcase (NYSE:SCS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Steelcase (NYSE:SCS – Get Free Report) announced its earnings results on Wednesday. The business services provider reported $0.39 earnings per...
Lawmakers Mull Revamp of Secret Service Funding, Policy After Trump Assassination Attempts
By Joseph Lord and Arjun Singh WASHINGTON, D.C.—In the aftermath of an apparent second attempted assassination of former President Donald...
In-Person Voting Begins in Virginia, South Dakota, and Minnesota
By Nathan Worcester Summer isn’t over, but America’s “election season” is already well underway. In fact, some people are now...